| Erhardt, J A; Legos, J J; Johanson, R A et al. (2000) Expression of PEP-19 inhibits apoptosis in PC12 cells. Neuroreport 11:3719-23 |
| Johanson, R A; Sarau, H M; Foley, J J et al. (2000) Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II In situ. J Neurosci 20:2860-6 |
| Smith, M L; Johanson, R A; Rogers, K E et al. (1998) Identification of a neuronal calmodulin-binding peptide, CAP-19, containing an IQ motif. Brain Res Mol Brain Res 62:12-24 |
| Slemmon, J R; Wengenack, T M; Flood, D G (1997) Profiling of endogenous peptides as a tool for studying development and neurological disease. Biopolymers 43:157-70 |
| Slemmon, J R; Morgan, J I; Fullerton, S M et al. (1996) Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, and neuromodulin. J Biol Chem 271:15911-7 |
| Martzen, M R; Slemmon, J R (1995) The dendritic peptide neurogranin can regulate a calmodulin-dependent target. J Neurochem 64:92-100 |
